| SC 13G/A | 2020-02-14 | Consonance Capital Management LP | Sesen Bio, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-10 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Sesen Bio, Inc. | 4,040,835 | 3.9% | EDGAR |
| SC 13G/A | 2020-02-10 | CVI Investments, Inc. | Sesen Bio, Inc. | 5,497,845 | 4.9% | EDGAR |
| SC 13G | 2019-06-28 | CVI Investments, Inc. | Sesen Bio, Inc. | 9,180,000 | 9.1% | EDGAR |
| SC 13G | 2019-02-14 | Consonance Capital Management LP | Sesen Bio, Inc. | 6,345,761 | 8.2% | EDGAR |
| SC 13G/A | 2019-02-04 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Sesen Bio, Inc. | 5,239,557 | 6.8% | EDGAR |
| SC 13G/A | 2019-01-04 | SABBY MANAGEMENT, LLC | Sesen Bio, Inc. | 3,306,773 | 4.3% | EDGAR |
| SC 13G | 2018-04-04 | KINGDON CAPITAL MANAGEMENT, L.L.C. | Eleven Biotherapeutics, Inc. | 2,213,980 | 5.1% | EDGAR |
| SC 13G | 2018-03-22 | SABBY MANAGEMENT, LLC | Eleven Biotherapeutics, Inc. | 3,187,251 | 7.4% | EDGAR |
| SC 13G/A | 2018-01-25 | Empery Asset Management, LP | Eleven Biotherapeutics, Inc. | 4,375,000 | 5.0% | EDGAR |
| SC 13G | 2017-11-08 | Empery Asset Management, LP | Eleven Biotherapeutics, Inc. | 3,000,000 | 10.0% | EDGAR |
| SC 13D/A | 2017-04-07 | Flagship Ventures Fund 2007, L.P. | Eleven Biotherapeutics, Inc. | 829,982 | 3.4% | EDGAR |
| SC 13G/A | 2017-02-14 | Boxer Capital, LLC | Eleven Biotherapeutics, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2017-01-09 | SABBY MANAGEMENT, LLC | Eleven Biotherapeutics, Inc. | 218,117 | 0.9% | EDGAR |
| SC 13D/A | 2016-11-30 | Flagship Ventures Fund 2007, L.P. | Eleven Biotherapeutics, Inc. | 1,090,887 | 4.5% | EDGAR |
| SC 13D/A | 2016-11-18 | Flagship Ventures Fund 2007, L.P. | Eleven Biotherapeutics, Inc. | 1,307,578 | 5.4% | EDGAR |
| SC 13D | 2016-09-28 | DAN LESLIE | Eleven Biotherapeutics, Inc. | 3,583,225 | 14.8% | EDGAR |
| SC 13D/A | 2016-09-23 | Flagship Ventures Fund 2007, L.P. | Eleven Biotherapeutics, Inc. | 1,833,802 | 7.6% | EDGAR |
| SC 13D/A | 2016-09-19 | Flagship Ventures Fund 2007, L.P. | Eleven Biotherapeutics, Inc. | 1,833,802 | 9.1% | EDGAR |
| SC 13G/A | 2016-06-14 | Boxer Capital, LLC | Eleven Biotherapeutics, Inc. | 1,255,412 | 6.3% | EDGAR |